Antibiotics and Lipid-Modifying Agents: Potential Drug-Drug Interactions and Their Clinical Implications
Evidence-based prescribing requires taking into consideration the many aspects of optimal drug administration (e.g., dosage, comorbidities, co-administered drugs, etc.). A key issue is the administration of drugs for acute disorders that may potentially interfere with previously prescribed long-term...
Saved in:
Main Authors: | Marios Spanakis (Author), Danny Alon-Ellenbogen (Author), Petros Ioannou (Author), Nikolaos Spernovasilis (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels-Potent Clinical Implications
by: Amalia Despoina Koutsogianni, et al.
Published: (2023) -
Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece
by: Marios Spanakis, et al.
Published: (2021) -
Real-World Data Regarding Dalbavancin Use before and during the COVID-19 Pandemic-A Single-Center Retrospective Study
by: Petros Ioannou, et al.
Published: (2023) -
In Silico Pharmacology for Evidence-Based and Precision Medicine
by: Marios Spanakis
Published: (2023) -
Molecular docking, drug-likeness and DFT study of some modified tetrahydrocurcumins as potential anticancer agents
by: Ahmed Mahal, et al.
Published: (2024)